Rivaroxaban Granule For Suspension
Product Images NDC 70748-355

Product Visual Gallery

This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Rivaroxaban Granule (NDC 70748-355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 179 1)

An illustrated oral dosing syringe for rivaroxaban granule for suspension showing colorful dose markings and measurement labels from 0.3 mL to 5 mL on a purple background. The syringe is designed for precise volume measurement when preparing suspension dosage.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 184 1)

An instructional illustration showing a purple oral dosing syringe for rivaroxaban granule suspension, with Side 1 marked in milliliters (mL) up to 5 mL and Side 2 displaying color bands that help measure specific doses. The diagram labels the syringe components as Tip and Plunger, noting the color bands assist in accurate dose withdrawal.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 186 1)

Instructional illustration showing a white bottle with a cap and a bottle adaptor attached. Text indicates not to remove the bottle adaptor from the bottle. This is related to rivaroxaban granule for suspension.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 190 1)

An instructional illustration showing hands being washed under running water indicated by blue water droplets. The diagram emphasizes hand hygiene, likely related to medication preparation or administration steps.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 203 1)

A dosing table showing the volume measures needed to achieve doses of rivaroxaban granule suspension. It lists doses of 7.5 mL, 10 mL, 15 mL, and 20 mL with their corresponding measurements in 5 mL increments. The table outlines how to combine multiple 5 mL measures to reach each total dose volume.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 207 1)

An instructional diagram showing a hand holding a bottle with its cap removed and an adaptor attached to the bottle neck. Another hand is inserting a measurement device, resembling a syringe or dropper, into the bottle adaptor. A blue downward arrow indicates the direction of insertion. The image is related to preparing or measuring rivaroxaban granule for suspension liquid oral administration.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 209 1)

An instructional illustration showing a hand holding a medicine bottle upside down with a syringe extracting a purple suspension liquid. A large blue arrow points downward, indicating the direction of liquid flow into the syringe. The image relates to preparation or dosage measurement of rivaroxaban granule for suspension.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 211 1)

A caution warning panel stating: Make sure you have enough medicine for a full dose. Do not take a partial dose. The text is displayed in red with a warning icon.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 211 2)

An instructional illustration showing hands preparing a suspension by shaking a bottle, with a close-up inset highlighting granules dissolving in the liquid inside the container. This image likely relates to the proper preparation of rivaroxaban granule oral suspension prior to use.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 215 1)

An instructional diagram depicting hands holding a syringe with a bottle on top. The image shows the action of drawing liquid from the bottle into the syringe, indicated by an upward-pointing arrow below the syringe.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 217 1)

An instructional illustration showing a hand holding a bottle labeled for suspension and another hand inserting a measuring device or dropper into the bottle, with an arrow indicating upward movement to lift the measuring device or dropper from the bottle.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 225 1)

A text panel with a warning in red font stating: "Do not place the oral dosing syringe in the dishwasher." This panel provides an instruction related to the use of the oral dosing syringe associated with the medication.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 258 1)

An instructional diagram showing a bottle labeled for rivaroxaban granule for suspension with a highlighted area indicating where to check the 'Discard after' date on the bottle's label.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 259 1)

An instructional diagram showing a hand holding and shaking a bottle slowly, with the word 'SLOW!' in blue letters. Text below instructs to shake the bottle slowly for 10 seconds before each use and warns against shaking too fast to avoid foaming, which may lead to inaccurate dosing.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 259 2)

An instructional illustration showing the correct positioning of a bottle for oral suspension medication, emphasizing viewing the bottle at eye level with a checkmark indicating the proper angle or alignment.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 260 1)

An instructional diagram showing a 5 mL oral syringe with colored segments and numeric measurements ranging approximately from 0.8 mL to 3 mL, likely indicating incremental dosing marks for rivaroxaban granule for suspension (155 mg/1).*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 261 1)

An instructional illustration showing a hand holding a dosing syringe for oral suspension. A magnified inset highlights the syringe tip, with an arrow pointing at the plunger cap to indicate proper use or positioning. No product text or specific measurements are visible.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 262 1)

An instructional illustration showing an adult hand administering oral medication to a child using a syringe placed near the child's mouth. The image demonstrates the proper method for giving rivaroxaban granule for suspension orally.*

FDA Label Image

Image (8093e0ec F2e1 469e 938c De910cbdb1f9 263 1)

An instructional illustration showing a person holding a measuring syringe in one hand and a tube in the other, with blue droplets falling into the tube, likely demonstrating how to measure and transfer liquid suspension.*

FDA Label Image

Image (C2a8f095 D977 4971 B77a 20feb09a6c3c 01)

Chemical structure of rivaroxaban, the active ingredient in rivaroxaban granule for suspension, shown as a molecular diagram with rings and functional groups including a chlorothiophene moiety.*

FDA Label Image

Image (C2a8f095 D977 4971 B77a 20feb09a6c3c 02)

A pharmacokinetic (PK) fold change graph depicting the effects of various conditions on rivaroxaban granule exposure, including end-stage renal disease, renal impairment, age, body weight, and hepatic impairment. The graph shows fold changes and 90% confidence intervals comparing Cmax and AUC values relative to reference groups for each population description.*

FDA Label Image

Image (C2a8f095 D977 4971 B77a 20feb09a6c3c 03)

A pharmacokinetic interaction chart showing fold changes and 90% confidence intervals for various drugs when taken with rivaroxaban granule. The chart categorizes drugs as Combined P-gp and Strong CYP3A Inhibitors, Combined P-gp and Moderate CYP3A Inhibitor, Moderate CYP3A Inhibitor, Combined P-gp and Strong CYP3A Inducer, and Other Drugs, displaying their impact on Cmax and AUC relative to rivaroxaban alone.*

FDA Label Image

Container Label (C2a8f095 D977 4971 B77a 20feb09a6c3c 04)

Label for rivaroxaban granule for oral suspension 1 mg/mL (when reconstituted) by Lupin Pharmaceuticals, Inc. The label includes instructions to shake slowly before each dose and warns to dispense the enclosed Medication Guide to patients. It indicates the bottle contains 155 mg rivaroxaban USP and is for oral use only. Storage instructions specify to keep upright, store at room temperature (20-25°C), not to freeze, and to keep out of reach of children. There is space to record the discard date. The label features a barcode and states the product is manufactured by Lupin Limited in India.*

FDA Label Image

Carton Label (C2a8f095 D977 4971 B77a 20feb09a6c3c 05)

Packaging label for Rivaroxaban for Oral Suspension granule, 1 mg/mL when reconstituted, by Lupin Pharmaceuticals, Inc. The carton displays NDC 70748-355-01 and includes contents: 1 bottle, 2 oral dosing syringes, 1 plastic bottle adaptor, and instructions for use. It contains pharmacist instructions and storage guidelines, with the label stating 'For Oral Use Only' and 'Rx only.'*

FDA Label Image

Image (C2a8f095 D977 4971 B77a 20feb09a6c3c 165 1)

FDA Label Image

Image (C2a8f095 D977 4971 B77a 20feb09a6c3c 168 1)

The image shows rectangular foil blister packaging containing round, brown rivaroxaban granule tablets. The packaging is partially transparent, revealing the tablets inside. There is no visible printed text or label on this portion of the packaging.*

FDA Label Image

Image (C2a8f095 D977 4971 B77a 20feb09a6c3c 230 1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.